NVE (NVEC) Q2 2025 earnings summary

Executive summary

• Reported strong earnings despite a 5% year-over-year revenue decline, with optimism for end-market recovery and growth in Industrial IoT and electrification.

• Net income for the quarter was $4.0 million, down 15% from the prior-year quarter, reflecting lower revenue, higher expenses, and a higher tax rate.

• Gross margin improved to 86% from 78% year-over-year, driven by a more profitable product mix and higher direct sales.

• Introduced a new high-sensitivity tunneling magnetoresistance rotation sensor, targeting factory automation, automotive, and medical device navigation markets.

• Components featured in NASA's Europa Clipper mission, validating product quality and reliability.

Financial highlights

• Quarterly revenue was $6.8 million, down 5% year-over-year, driven by a 14% drop in product sales, partially offset by a 3,950% surge in contract R&D revenue.

• Net income for the quarter: $4.0 million, or $0.83 per diluted share, compared to $4.7 million, or $0.98 per diluted share, a year ago.

• Six-month revenue: $13.5 million, down 15% year-over-year; six-month net income: $8.12 million, or $1.68 per diluted share.

• Cash and cash equivalents at quarter-end: $3.1 million, down from $10.3 million at March 31, 2024, due to investing and financing outflows.

• Declared quarterly cash dividend of $1.00 per share to be paid November 29, 2024.

Outlook and guidance

• Management remains optimistic about long-term growth, citing improving end markets and strong prospects in defense, Industrial IoT, and medical devices.

• Distributor channel inventory is being depleted, which is expected to lead to a rebound in distributor sales.

• Some new products related to recent capital investments are expected to enter production by the end of fiscal 2025.

• Management anticipates increased fixed asset purchases in fiscal 2025 and 2026 to support production capacity and new product development.

• Dividends are expected to be funded through operating cash flow and maturities of marketable securities, subject to Board approval and company performance.